Evidence map›Paper›PMID 33842404›Full record

ArticleJournal of cancer prevention2021

Dysregulated Free Fatty Acid Receptor 2 Exacerbates Colonic Adenoma Formation in

Yi-Wen Huang, Chien-Wei Lin, Pan Pan, Carla Elena Echeveste, Athena Dong, Kiyoko Oshima, Martha Yearsley, Jianhua Yu, Li-Shu Wang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer prevention, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Protective Effects of Ganoderic Acids fromFoods (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yi-Wen HuangDepartment of Obstetrics & Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID https://orcid.org/0000-0001-9220-8770
Chien-Wei LinDivision of Biostatistics, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID https://orcid.org/0000-0003-4023-7339
Pan PanDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID https://orcid.org/0000-0002-9573-9443
Carla Elena EchevesteDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID https://orcid.org/0000-0001-8442-0683
Athena DongDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID https://orcid.org/0000-0002-9195-9107
Kiyoko OshimaDepartment of Pathology, Johns Hopkins University, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-3357-6247
Martha YearsleyDepartment of Pathology, The Ohio State University, Columbus, OH, USA.ORCID https://orcid.org/0000-0003-0352-1277
Jianhua YuDepartment of Hematology and Hematopoietic Cell Transplantation, Comprehensive Cancer Center, City of Hope National Medical Center, Duarte, CA, USA.ORCID https://orcid.org/0000-0002-0326-3223
Li-Shu WangDivision of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID https://orcid.org/0000-0002-6500-6943
Medical College of Wisconsin · USCity Of Hope National Medical Center · USJohns Hopkins University · USThe Ohio State University · US

Funding

Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK CellsR01CA247550 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI YU, JIANHUA · 2020 to 2024
$2.2M
Elucidate and Modulate Cell Signaling in NK Cells for Glioma TreatmentR01AI129582 · NIAID · OHIO STATE UNIVERSITY · PI YU, JIANHUA · 2017 to 2021
$2.1M
Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-CadherinR01NS106170 · NINDS · OHIO STATE UNIVERSITY · PI YU, JIANHUA · 2018 to 2023
$1.9M
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer PreventionR01CA185301 · NCI · OHIO STATE UNIVERSITY · PI CALIGIURI, MICHAEL A, YU, JIANHUA · 2015 to 2019
$1.8M
Mechanisms of tumor suppressor gene reactivation in colon cancer by berriesR01CA148818 · NCI · OHIO STATE UNIVERSITY · PI WANG, LI-SHU · 2010 to 2014
$1.5M
scFvPD1-FLT3 CAR T Cells for the Treatment of Relapsed Acute Myeloid LeukemiaR21CA223400 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI YU, JIANHUA · 2019 to 2020
$414k
NCI NIH HHS R01 CA148818NCI NIH HHS R01 CA185301NCI NIH HHS R01 CA247550NCI NIH HHS R21 CA223400NIAID NIH HHS R01 AI129582NINDS NIH HHS R01 NS106170
6 · The paper itself

Abstract

Free fatty acid receptor 2 (

Indexed as

ApcMin/+Colorectal cancerFfar2Gut microbiotaMetabolomics

Identifiers

PMID33842404
PMCPMC8020170
OpenAlexW3147518160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.